The Lifespan Extension Advocacy Foundation is announcing Ending Age-Related Diseases 2019 – a 2-day conference in New York City to foster the development of rejuvenation biotechnology
NEW YORK, January. 10, 2018 — After the incredible success of the conference Ending Age-Related Diseases 2018, the Lifespan Extension Advocacy Foundation is happy to announce its second annual conference, Ending Age-Related Diseases 2019, which is to be held at Cooper Union in New York City on July 11-12th, 2019.
The conference is aimed at focusing the NYC business community’s attention on the current state of aging and rejuvenation research that has the potential to prevent and cure age-related diseases. With multiple research projects targeting the underlying processes of aging in order to develop preventive medicines, promoting collaboration between academia, the rejuvenation industry, and investors becomes an increasingly important task.
The list of confirmed speakers already includes renowned researchers and visionaries, such as Dr. Aubrey de Grey (SENS Research Foundation), Michael Greve (KIZOO Technology Ventures, Forever Healthy Foundation), Dr. Vadim Gladyshev (Harvard Medical School), Dr. Vera Gorbunova (University of Rochester), Dr. Alex Zhavoronkov (Insilico Medicine), and Reason and Bill Cherman (Repair Biotechnologies), with more speakers from rejuvenation biotechnology companies and the investment sector to be confirmed soon.
Keith Comito, president of the Lifespan Extension Advocacy Foundation, describes the conference as follows:
This year’s conference will focus on two main topics. The first topic will be progress in aging research, from fundamental studies to the interventions that are being tested in human clinical trials and the development of reliable biomarkers of aging. The second topic will be devoted to the hurdles of implementing these emerging rejuvenation biotechnologies into clinical practice, with a special focus on investment, the regulatory landscape, and the preparedness of the medical community. This way, we hope not only to attract the attention of investors to these very promising medical innovations but also to promote public dialogue on how to ensure their availability and accessibility to our aging society.
Ending Age-Related Diseases 2019 is not only open to the scientific community but welcomes everyone who is interested in aging and rejuvenation research.
To register for Ending Age-Related Diseases 2019, please proceed to the conference page on Eventbrite.
ABOUT THE Lifespan Extension Advocacy Foundation
The Lifespan Extension Advocacy Foundation is a nonprofit 501(c)(3) organization dedicated to promoting life extension, longevity, and aging research through crowdfunding and advocacy initiatives. Its mission is to connect the researchers and scientists developing the latest advancements with the people who support them through initiatives such as Lifespan.io. To date, more than $300,000 has been collected by Lifespan.io in support of 7 studies.
LEAF hosts the Rejuvenation Roadmap, a curated database of various drugs and therapies that target the main mechanisms of aging, helping the public to visualize their developmental pipeline through preclinical stages, human clinical trials, and final approval.
LEAF also runs the Longevity Investor Network, which organizes pitch sessions and connects new biotech companies with investors.
To request a press pass, please contact Elena Milova.